Drug intelligence / Profile preview

acalypha australis

Development stage
Preclinical
Administration
Oral
01

Overview

**Acalypha australis** is a herbaceous annual plant in the family Euphorbiaceae, commonly known as Asian copperleaf or copperleaf. It is traditionally used in Chinese medicine for its purported effects on hemostasis (stopping bleeding), detoxification, heat clearance, and has historical usage for treating conditions like diarrhea, dysentery, snakebite, nosebleed, dermatitis, ulcerative colitis, and cough[1][2][3][5][6][7][8]. Pharmacological studies suggest its mechanisms may include anti-inflammatory effects (notably via NF-κB pathway inhibition), anti-obesity effects (through regulation of adipogenesis by suppressing PPARγ and CEBP/α expression), as well as possible antibacterial, antidiabetic, anticancer, and detoxifying actions[1][3][7]. Recent animal studies indicate potential benefit in mitigating ulcerative colitis and improving metabolic parameters related to obesity and lipid metabolism[1][3]. Its active constituents include flavonoids, with individual compounds such as 4-hydroxybenzoic acid methyl ester, 3-methoxy-4-hydroxybenzoic acid, and protocatechuic acid proposed to mediate some effects[1].

Other names
Asian copperleafcopperleafAcalypha australis L.AAL
02

Targets

CEBPA (CCAAT enhancer-binding protein alpha)FABP4 (Fatty acid-binding protein 4)NF-κBPPARG (Peroxisome proliferator-activated receptor gamma)

Beyond the preview

Go deeper on acalypha australis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acalypha australis.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call